Oxford Global Q&A Session with Taros’ SVP Drug Discovery
Delivering Innovative Drug Discovery Starting Points
Dortmund, January 2020 ++++
Ahead of Oxford Global’s R&D Series Drug Discovery Series Virtual on 29-30 July 2020, Germany, Oxford Global spoke to Taros Senior Vice President Drug Discovery Torsten Hoffmann about his work in Pharmaceutical R&D and the opportunities and challenges in Drug Discovery. Besides Torsten Hoffmann Taros CEO Dimitrios Tzalis will attend the event as speaker, both presentation and panel discussion, and as moderator.
Read the full interview here
Oxford Global is the specialist for cutting edge Congresses & Summits for the Life Sciences industry in the UK, Europe and USA.
About Taros Chemicals
Taros is a privately owned discovery chemistry company, working with global pharmaceutical, biotech and chemical companies since 1999. Alongside our performance chemicals and material science division, Taros’ drug discovery mission is to create drug candidates as potential new medicines. Taros has a strong scientific track record on many biomolecular targets in all main therapeutic areas and thereby adding considerable value to collaborations from target validation and hit identification to lead generation and optimization. Taros’ core expertise ranges from custom synthesis and process development to modern medicinal and computational chemistry, as well as compound library design and production.
Taros was heading the chemistry efforts of the EUR 196 million funded European Lead Factory (2013-2018) and is currently heading its EUR 36.5 million funded continuation (2019-2022). Moreover, Taros is deeply engaged in other research alliances like the EUR 11 million funded Drug Discovery Hub Dortmund.
Youri R. Mesmoudi, Executive Vice President, e-mail: innovation |at| taros.de
As a leading CRO in Europe, Taros provides comprehensive drug discovery chemistry services for large Pharma and Biotech corporations as well as for Research Institutes and Academia
Our experienced chemists practice a pragmatic culture and customer-centric approach in order to exceed project expectations and, despite challenges, bridge very narrow timelines. They are trained to consider economic, safety and ecological boundaries and conditions laid out for all stages of the project.